Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors

  1. García, M.
  2. Bonafont, J.
  3. Martínez-Palacios, J.
  4. Xu, R.
  5. Turchiano, G.
  6. Svensson, S.
  7. Thrasher, A.J.
  8. Larcher, F.
  9. Del Rio, M.
  10. Hernández-Alcoceba, R.
  11. Garín, M.I.
  12. Mencía, Á.
  13. Murillas, R.
Journal:
Molecular Therapy - Methods and Clinical Development

ISSN: 2329-0501

Year of publication: 2022

Volume: 27

Pages: 96-108

Type: Article

DOI: 10.1016/J.OMTM.2022.09.005 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus